Evidence map›Paper›PMID 40315350›Full record

ArticleInorganic chemistry2025

Generation of [(N4Py)Fe(IV)═O]

Juan Chen, Andy S Sardjan, C Maurits de Roo, Marika Di Berto Mancini, Apparao Draksharapu, Davide Angelone, Ronald Hage, Marcel Swart, Wesley R Browne

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Inorganic chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Realising the ambivalent nature of HDalton transactions (Cambridge, England : 2003) · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Juan ChenDepartment of Applied Chemistry, School of Science, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China.ORCID 0000-0002-0168-2037
Andy S SardjanMolecular Inorganic Chemistry, Stratingh Institute for Chemistry, Faculty of Science and Engineering, University of Groningen, Nijenborgh 3, 9747 AG Groningen, The Netherlands.
C Maurits de RooMolecular Inorganic Chemistry, Stratingh Institute for Chemistry, Faculty of Science and Engineering, University of Groningen, Nijenborgh 3, 9747 AG Groningen, The Netherlands.ORCID 0009-0004-1493-9809
Marika Di Berto ManciniMolecular Inorganic Chemistry, Stratingh Institute for Chemistry, Faculty of Science and Engineering, University of Groningen, Nijenborgh 3, 9747 AG Groningen, The Netherlands.
Apparao DraksharapuMolecular Inorganic Chemistry, Stratingh Institute for Chemistry, Faculty of Science and Engineering, University of Groningen, Nijenborgh 3, 9747 AG Groningen, The Netherlands.ORCID 0000-0001-7897-3230
Davide AngeloneMolecular Inorganic Chemistry, Stratingh Institute for Chemistry, Faculty of Science and Engineering, University of Groningen, Nijenborgh 3, 9747 AG Groningen, The Netherlands.
Ronald HageMolecular Inorganic Chemistry, Stratingh Institute for Chemistry, Faculty of Science and Engineering, University of Groningen, Nijenborgh 3, 9747 AG Groningen, The Netherlands.
Marcel SwartICREA, Pg. Lluis Companys 23, 08010 Barcelona, Spain.ORCID 0000-0002-8174-8488
Wesley R BrowneMolecular Inorganic Chemistry, Stratingh Institute for Chemistry, Faculty of Science and Engineering, University of Groningen, Nijenborgh 3, 9747 AG Groningen, The Netherlands.ORCID 0000-0001-5063-6961

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-valent Fe(IV) oxido species are important intermediates in the catalyzed oxidation of organic compounds by nonheme iron enzymes. These species can be generated in biomimetic model complexes directly using oxygen atom transfer oxidants, e.g., PhIO and ClO

Identifiers

PMID40315350
PMCPMC12093294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.